BofA on Eli Lilly (LLY): 'Novo’s GLP-1 price update unlikely to ‘rock the boat’'

February 24, 2026 10:11 AM EST Send to a Friend
BofA Securities analyst Tim Anderson reiterated a Buy rating and $1,293.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login